The DOI matches its Crossref record.
Immediate Neurocognitive Effects of Methylphenidate on Learning-Impaired Survivors of Childhood Cancer
Abstract
PURPOSE: To test if methylphenidate (MPH) has an objective beneficial effect on immediate performance on tests of neurocognitive functions among learning-impaired survivors of childhood acute lymphoblastic leukemia (ALL) and malignant brain tumors (BT). PATIENTS AND METHODS: From July 1, 1997 through December 31, 1998, 104 long-term survivors of childhood ALL or a malignant BT completed neurocognitive screening for learning impairments and concurrent problems with sustained attention. Eligibility criteria for the MPH trial included an estimated intelligence quotient greater than 50, academic achievement in the 16 th percentile or lower for age in reading, math, or spelling, and an ability to sustain attention on a computerized version of the Conners’ Continuous Performance Test (CPT) in the 16 th percentile or lower for age and sex. Of the 104, 32 (BT, n = 25; ALL, n = 7) were eligible on the basis of these a priori criteria for a randomized, double-blinded, placebo-controlled trial of MPH. The patients ingested a placebo (lactose) or MPH (0.6 mg/kg; 20 mg maximum) and repeated selected portions of the screening battery 90 minutes later. RESULTS: Compared to the 17 patients randomized to the placebo group, the 15 patients randomized to the MPH group had a significantly greater improvement on the CPT for sustained attention (errors of omission, P = .015) and overall index (P = .008) but not for errors of commission (indicative of impulsiveness) nor reaction times. A trend for greater improvement in the MPH group on a measure of verbal memory failed to reach statistical significance. No trend was observed for MPH effectiveness in improving learning of a word association task. No significant side effects from MPH were observed. CONCLUSION: MPH resulted in a statistically significant improvement on measures of attention abilities that cannot be explained by placebo or practice effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Late neurocognitive sequelae in survivors of brain tumours in childhood
Mulhern, R. K., Merchant, T. E., Gajjar, A., Reddick, W. E., & Kun, L. E. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01507-4 · Cited by 872
Self-citationCognitive Impairment Associated With Chemotherapy for Cancer: Report of a Workshop
Tannock, I. F., Ahles, T. A., Ganz, P. A., & van Dam, F. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.094 · Cited by 453
Change in Neurocognitive Functioning After Treatment With Cranial Radiation in Childhood
Spiegler, B. J., Bouffet, E., Greenberg, M. L., Rutka, J. T., & Mabbott, D. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.186 · Cited by 409
Trends and advances in cancer survivorship research: challenge and opportunity
AZIZ, N., & ROWLAND, J. (2003) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(03)00024-9 · Cited by 330
Reddick, W. E., White, H. A., Glass, J. O., Wheeler, G. C., Thompson, S. J., Gajjar, A., Leigh, L., & Mulhern, R. K. (2003) · Cancer · doi:10.1002/cncr.11355 · Cited by 275
Self-citation
Metadata
- Authors
- Thompson, S. J., Leigh, L., Christensen, R., Xiong, X., Kun, L. E., Heideman, R. L., Reddick, W. E., Gajjar, A., Merchant, T., Pui, C.-H., Hudson, M. M., & Mulhern, R. K.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-03-15
- Volume
- 19
- Issue
- 6
- Pages
- 1802-1808
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1876901557
- Cited by
- 180
- References
- 0
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immediate Neurocognitive Effects of Methylphenidate on Learning-Impaired Survivors of Childhood Cancer. https://app.cochat.ai/papers/10.1200/jco.2001.19.6.1802
- The paper
- Thompson, S. J., Leigh, L., Christensen, R., Xiong, X., Kun, L. E., Heideman, R. L., Reddick, W. E., Gajjar, A., Merchant, T., Pui, C.-H., Hudson, M. M., & Mulhern, R. K. (2001). Immediate Neurocognitive Effects of Methylphenidate on Learning-Impaired Survivors of Childhood Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2001.19.6.1802
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.